A purple and pink letter v on a white background.
June 23, 2021

How Having Both ARTAS® iX and NeoGraft® Can Benefit Your Clinic

Offering the best hair restoration technology at your clinic is an important first step to taking part in this exciting $4.9 billion industry. Hair restoration is a growing market that continues to attract a larger customer base each year, and competition among aesthetic practices is keeping pace. It’s never been more important to keep abreast of the latest in technology, consumer trends, and procedural methods if you want to stay ahead. The latest scientific advances in hair restoration have made this popular procedure better, more versatile, and more lucrative for treatment providers. Venus Concept’s two state-of-the-art devices, NeoGraft® and ARTAS® iX, have different modes of utility which make them ideal for appealing to a broad client base. Together, they can establish your clinic as a center of hair restoration success. Read on to learn more about the technology that makes these two devices work in tandem to deliver excellent hair restoration results across the board.

  Why Two Devices Are Better Than One  

A review of the current hair restoration market data gives an overview of how diverse the customer base for this procedure is. Last year, the majority of hair transplant procedures targeted the scalp area. This accounted for 85% of procedures performed on men, and 82% of those for women. These are considered high volume cases, since hair restoration on the scalp area tends to require a higher number of individual grafts. ARTAS® iX, which uses robotic FUE enhanced by Artificial Intelligence design, is best at handling these high volume cases, maximizing each follicle transplantation for natural-looking results and repeatability.  

Automated FUE with NeoGraft is ideal for:

  • Female clients
  • Lower volume cases
  • Curly Hair
  • Light and blond hair
  • Specific areas of the scalp such as temples, widow’s peak
  • Post-face lift hairline fine-tuning

Robotic FUE with ARTAS iX™ is ideal for:

  • Male clients
  • High volume cases
  • Assisted grafting with AI and robotic systems
  • Faster and higher yield procedures
  • Attracting clients who want the latest in cutting edge technology
  • Increased precision, efficiency, and repeatability

Hair Restoration With ARTAS iX & NeoGraft®

With a record number of ARTAS® iX procedures performed last year, there’s no denying the popularity of this state-of-the-art hair restoration device. Every year, more providers turn to the superiority of automated FUE, the robotically-assisted FUE technique, and particularly FUE devices augmented with advanced technology.

ARTAS® iX makes hair restoration procedures swift and seamless, using Artificial Intelligence (AI) to design the ideal extraction and placement of the hair follicles. The device’s precision and speed work to protect existing hair and maintains a natural appearance for the newly implanted hair. The innovative system leverages state-of-the-art technology to enable accurate and efficient harvesting, recipient site-making, and implantation functionality in one device, using image-guided robotics for precise and repeatable follicular unit dissection.

With NeoGraft® , the automated system supplants the need for linear grafts by extracting individual hair follicles. The highly specialized pneumatic arm then implants them in the area where more hair growth is desired. The newly implanted hair follicles continue the natural hair growth cycle and results improve each week, with full realization at 9-12 months post-procedure. In both cases, the procedure is minimally invasive, less painful, leaves no linear scarring, and requires very little in terms of recovery or aftercare.

With both devices, we offer full clinic support with VERO Hair™ ,  a comprehensive solution for growing your hair restoration business. It includes both our automated and advanced robotic FUE technologies as well as extensive post-sales support tools, including clinical training, marketing, and business development programs, giving you the competitive edge in the expanding hair restoration market. Speak to one of our experts today to see how we can support your success.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.